|Journal||JNCCN Journal of the National Comprehensive Cancer Network|
|State||Published - Nov 2021|
Bibliographical noteFunding Information:
Disclosures: P.M. Cinciripini has disclosed receiving nonmonetary research support from Pfizer. G.W. Warren has disclosed participating in research for the Agency for Healthcare Research and Quality and serving as a consultant for the Canadian Partnership Against Cancer. The remaining individuals have disclosed no relevant financial relationships.
Funding: This supplement was funded by the C3I Coordinating Center contract from the National Cancer Institute (CRDF Award #66590). In addition, authors received funding for their C3I participation via a supplement to their NCI P30 cancer center support grant during the period 2017–2021.
ASJC Scopus subject areas